985
Views
0
CrossRef citations to date
0
Altmetric
Cancer Biology

Investigation of two ferroptosis-related molecular subtypes and biomarkers in the progression of gastric adenocarcinoma

, , , , , , & show all
Pages 537-546 | Received 01 Sep 2021, Accepted 07 Apr 2022, Published online: 06 May 2022

References

  • Abdi H, Williams LJ. 2010. Principal component analysis. Wiley Interdisciplinary Rev: Comput Stat. 2:433–459.
  • Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. 2017. Gastric adenocarcinoma. Nat Rev Dis Primers. 3:1–19.
  • Angeli JPF, Krysko DV, Conrad M. 2019. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 19:405–414.
  • Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene Ontology: tool for the unification of biology. Nat Genet. 25:25–29.
  • Banks M, Graham D, Jansen M, Gotoda T, Coda S, Di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ. 2019. British society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 68:1545–1575.
  • Chang C, Worley BL, Phaëton R, Hempel N. 2020. Extracellular glutathione peroxidase GPx3 and its role in cancer. Cancers (Basel). 12:2197.
  • Correa P. 2013. Gastric cancer: overview. Gastroenterol Clin North Am. 42:211.
  • Dias AR, Azevedo BC, Alban LBV, Yagi OK, Ramos M, Jacob CE, Barchi LC, Cecconello I, Ribeiro U, Jr., Zilberstein B. 2017. Gastric neuroendocrine tumoe: review and update. Arquivos Brasileiros de Cirurgia Digestiva: ABCD = Brazilian Archives of Digestive Surgery. 30:150–154.
  • Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. 2005. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 241:27.
  • Gu Y, Li T, Kapoor A, Major P, Tang D. 2020. Contactin 1: An important and Emerging oncogenic protein promoting cancer progression and metastasis. Genes (Basel). 11:874.
  • Hänzelmann S, Castelo R, Guinney J. 2013. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 14:7.
  • Hu W, Li S, Zhang S, Xie B, Zheng M, Sun J, Yang X, Zang L. 2020. GJA1 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer. Cancer Manag. Res. 12:11649–11661.
  • Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. 2003. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res. 9:4404–4408.
  • Kanehisa M, Goto S. 2000. KEGG: Kyoto Encyclopedia of Genes and genomes. Nucleic Acids Res. 28:27–30.
  • Kang BW, Kim JG, Lee IH, Bae HI, Seo AN. 2017. Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology. World J Gastrointest Oncol. 9:293.
  • Kwong MLM, Denham L, Selleck MJ, Kim C, Kunihira K, Kubba R, Rojas R, Garberoglio C, Senthil M. 2019. Response to neoadjuvant treatment Is influenced by grade in gastric cancer. Am Surg. 85:1419–1422.
  • Lee J-Y, Nam M, Son HY, Hyun K, Jang SY, Kim JW, Kim MW, Jung Y, Jang E, Yoon S-J. 2020. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci USA. 117:32433–32442.
  • Li J, Cao F, Yin H-L, Huang Z-J, Lin Z-T, Mao N, Sun B, Wang G. 2020. Ferroptosis: past, present and future. Cell Death Dis. 11:1–13.
  • Liang J-Y, Wang D-S, Lin H-C, Chen X-X, Yang H, Zheng Y, Li Y-H. 2020. A novel ferroptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma. Int J Biol Sci. 16:2430.
  • Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. 2011. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 27:1739–1740.
  • Li-fang SHI, Shu-fang2A ZHENG, Yong-gang ZHAO, Jian-wei WANG, Xiao-hong ZHAN. 2011. Expressions of SNCG in gastric adenocarcinoma and its clinical significances. Prog Mod Biomed. 11:1532–1535.
  • Liu H-J, Hu H-M, Li G-Z, Zhang Y, Wu F, Liu X, Wang K-Y, Zhang C-B, Jiang T. 2020a. Ferroptosis-related gene signature predicts glioma cell death and glioma patient progression. Front Cell Dev Biol. 8:538.
  • Liu T, Sun H, Liu S, Yang Z, Li L, Yao N, Cheng S, Dong X, Liang X, Chen C. 2018. The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer. Int J Med Sci. 15:738.
  • Liu Z, Zhao Q, Zuo Z-X, Yuan S-Q, Yu K, Zhang Q, Zhang X, Sheng H, Ju H-Q, Cheng H. 2020b. Systematic analysis of the aberrances and functional implications of ferroptosis in cancer. Iscience. 23:101302.
  • Logan M, Anderson PD, Saab ST, Hameed O, Abdulkadir SA. 2013. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis. Am J Pathol. 183:951–963.
  • Luo Z, Wang W, Li F, Songyang Z, Feng X, Xin C, Dai Z, Xiong Y. 2019. Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes. Mol Cancer. 18:1–15.
  • Lyu JH, Park DW, Huang B, Kang SH, Lee SJ, Lee C, Bae YS, Lee JG, Baek SH. 2015. RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway. J Cell Biochem. 116:260–267.
  • Mhawech-Fauceglia P, Wang D, Syriac S, Godoy H, Dupont N, Liu S, Odunsi K. 2012. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma. Gynecol Oncol. 124:148–152.
  • Moreira AM, Pereira J, Melo S, Fernandes MS, Carneiro P, Seruca R, Figueiredo J. 2020. The extracellular matrix: an accomplice in gastric cancer development and progression. Cells. 9:394.
  • Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. 2015. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 12:453–457.
  • Nie J, Lin B, Zhou M, Wu L, Zheng T. 2018. Role of ferroptosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 144:2329–2337.
  • Nirgude S, Choudhary B. 2021. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem. Pharmacol. 184:114365.
  • Niu G, Zhang X, Hong R, Yang X, Gu J, Song T, Hu Z, Chen L, Wang X, Xia J, et al. 2021. GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial-mesenchymal transition of hepatic stellate cells. Open Medicine (Warsaw, Poland). 16:1459–1471.
  • Peng Z, Wang C-X, Fang E-H, Wang G-B, Tong Q. 2014. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol. 20:5403.
  • Pernot S, Terme M, Radosevic-Robin N, Castan F, Badoual C, Marcheteau E, Penault-Llorca F, Bouche O, Bennouna J, Francois E. 2020. Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the lauren classification and its prognostic significance. Gastric Cancer. 23:73–81.
  • Pils D, Hager G, Tong D, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I. 2012. Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD consortium. Cancer Sci. 103:1334–1341.
  • Rosso D, Rigueiro MP, Kassab P, Ilias EJ, Castro O, Novo NF, Lourenço LG. 2012. Correlation of natural killer cells with the prognosis of gastric adenocarcinoma. Arquivos Brasileiros de Cirurgia Digestiva: ABCD = Brazilian Archives of Digestive Surgery. 25:114–117.
  • Seibt TM, Proneth B, Conrad M. 2019. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radical Biol Med. 133:144–152.
  • Shen H, Wang L, Chen Q, Xu J, Zhang J, Fang L, Wang J, Fan W. 2020. The prognostic value of COL3A1/FBN1/COL5A2/SPARC-mir-29a-3p-H19 associated ceRNA network in gastric cancer through bioinformatic exploration. J Cancer. 11:4933.
  • Shen J, Zhang Y, Yu H, Shen B, Liang Y, Jin R, Liu X, Shi L, Cai X. 2016. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy. Cancer Med. 5:2061–2068.
  • Tai Y-L, Chen L-C, Shen T-L. 2015. Emerging roles of focal adhesion kinase in cancer. BioMed Res Int. 2015:690690.
  • Teng F, Xu Z, Chen J, Zheng G, Zheng G, Lv H, Wang Y, Wang L, Cheng X. 2018. DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer. Oncol Rep. 40:1203–1222.
  • Tomczak K, Czerwińska P, Wiznerowicz M. 2015. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 19:A68.
  • Utsunomiya T, Ogawa K, Yoshinaga K, Ohta M, Yamashita K, Mimori K, Inoue H, Ezaki T, Yoshikawa Y, Mori M. 2005. Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma. Int J Cancer. 116:105–109.
  • Van Loon K, Yemelyanenko-Lyalenko J, Margadant C, Griffioen AW, Huijbers EJM. 2020. Role of fibrillin-2 in the control of TGF-β activation in tumor angiogenesis and connective tissue disorders. Biochimica et Biophysica Acta. Reviews on Cancer. 1873:188354.
  • Walker C, Mojares E. 2018. Del Río hernández A. 2018.role of extracellular matrix in development and cancer progression. Int J Mol Sci. 19:3028.
  • Wenta T, Zurawa-Janicka D, Rychlowski M, Jarzab M, Glaza P, Lipinska A, Bienkowska-Szewczyk K, Herman-Antosiewicz A, Skorko-Glonek J, Lipinska B. 2018. Htra3 is a cellular partner of cytoskeleton proteins and TCP1α chaperonin. J Proteomics. 177:88–111.
  • Wickham H, Chang W, Wickham MH. 2016. Package ‘ggplot2’. create elegant data visualisations using the grammar of graphics. Version. 2:1–189.
  • Worley BL, Kim YS, Mardini J, Zaman R, Leon KE, Vallur PG, Nduwumwami A, Warrick JI, Timmins PF, Kesterson JP. 2019. GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment. Redox Biol. 25:101051.
  • Xie Y, Kuang F, Liu J, Tang D, Kang R. 2020. DUSP1 blocks autophagy-dependent ferroptosis in pancreatic cancer. J Pancreatology. 3:154–160.
  • Yang D, Zhao D, Chen X. 2017. MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression. Cancer Biomark. 19:425–436.
  • Yang S, Shin J, Park KH, Jeung H-C, Rha SY, Noh SH, Yang WI, Chung HC. 2007. Molecular basis of the differences between normal and tumor tissues of gastric cancer. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1772:1033–1040.
  • Zhang J, Liu XH, Li C, Wu XX, Chen YL, Li WW, Li X, Gong F, Tang Q, Jiang D. 2020. SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway. J Exp Clin Cancer Res. 39:79.
  • Zhang X, Du L, Qiao Y, Zhang X, Zheng W, Wu Q, Chen Y, Zhu G, Liu Y, Bian Z. 2019. Ferroptosis is governed by differential regulation of transcription in liver cancer. Redox Biol. 24:101211.
  • Zheng S, Shi L, Zhang Y, He T. 2014. Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance. Int J Clin Exp Pathol. 7:6606.
  • Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. 2019. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 10:1523.
  • Zou W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 6:295–307.